Featured Press Releases

Improved Pharma Brings Onboard Micro-DSC Hot-Stage System

Improved Pharma Brings Onboard Micro-DSC Hot-Stage System

Kimera® Labs named a semifinalist in the $101 million XPRIZE Healthspan competition for pioneering innovations in healthy aging

Kimera® Labs named a semifinalist in the $101 million XPRIZE Healthspan competition for pioneering innovations in healthy aging

  • 12 May 2025

Kimera Labs, Inc., the pioneer in therapeutic exosome biotechnology, is proud to announce its...

Leqembi Secures Approval for Alzheimer

Leqembi Secures Approval for Alzheimer's Disease Treatment in Hong Kong

Matthew Fyfe has been appointed as Chief Scientific Officer as Outrun Therapeutics expands its leadership team

Matthew Fyfe has been appointed as Chief Scientific Officer as Outrun Therapeutics expands its leadership team

Boehringer Ingelheim launches swine vaccine with advanced protection against Porcine Circovirus Type 2 in the U.S

Boehringer Ingelheim launches swine vaccine with advanced protection against Porcine Circovirus Type 2 in the U.S

Lundbeck Receives Marketing Authorization in South Korea for Vyepti® (eptinezumab) for the Preventive Treatment of Migraine

Lundbeck Receives Marketing Authorization in South Korea for Vyepti® (eptinezumab) for the Preventive Treatment of Migraine

Industry Veteran Marie Emms Appointed President of Clinical Business at Spectrum Science

Industry Veteran Marie Emms Appointed President of Clinical Business at Spectrum Science

  • Spectrum Science
  • 08 Jul 2026
Cannabix Technologies and Omega Laboratories Announce a DOT-Like Breath-Based Drug Testing Panel for Recent-Use Detection

Cannabix Technologies and Omega Laboratories Announce a DOT-Like Breath-Based Drug Testing Panel for Recent-Use Detection

  • Omega Laboratories, Inc.
  • 08 Jul 2026
Organon to Present New Analysis of VTAMA® (tapinarof) Cream, 1%

Organon to Present New Analysis of VTAMA® (tapinarof) Cream, 1%

  • Organon
  • 07 Jul 2026
European Commission Approves AbbVie

European Commission Approves AbbVie's TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab for the Treatment of Relapsed or Refractory Follicular Lymphoma

  • AbbVie
  • 06 Jul 2026
Nnamdi Njoku Named President of Omnicell

Nnamdi Njoku Named President of Omnicell

  • Omnicell, Inc.
  • 01 Jul 2026
Eligible Medicare Beneficiaries Living with Obesity Can Now Access Wegovy® Through the Medicare GLP-1 Bridge

Eligible Medicare Beneficiaries Living with Obesity Can Now Access Wegovy® Through the Medicare GLP-1 Bridge

  • Novo Nordisk
  • 01 Jul 2026
The Digital Pharma Advances Conference 2026

Most Popular
July   2026
M T W T F S S
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.